Study Stopped
Decision of investigational team
A Multicenter Study to Evaluate Functional Outcome After Knee Replacement
A Prospective, Multicenter Study to Evaluate Functional Outcome After Knee Replacement
1 other identifier
interventional
215
1 country
8
Brief Summary
Patients will be consecutively enrolled by implant. Implant groups will be those who have undergone surgery with either a ConforMIS iTotal® CR TKA or an Off-the- Shelf (OTS) system. The patient will conduct functional testing and answer questionnaires. The results will compare the ConforMIS iTotal with an Off the Shelf Knee replacement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2015
Longer than P75 for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2015
CompletedStudy Start
First participant enrolled
July 1, 2015
CompletedFirst Posted
Study publicly available on registry
July 10, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2022
CompletedResults Posted
Study results publicly available
October 8, 2025
CompletedNovember 21, 2025
November 1, 2025
7.4 years
May 28, 2015
August 22, 2025
November 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Activities Subscale Score Within the Knee Society Score (KSS) Measure
Comparing the functional testing differences between iTotal and off the shelf. "Total Functional Activities Score" - a subscale within the Knee Society Score (KSS) with its individual subscale score. The Total Functional Activities Score subscale interprets the functional knee health of each patient via a series of tests such as walking/standing (30 points), standard activities (30 points), advanced activities (25 points), and sports/recreational activities (15 points). Deductions to score are made for factors that limit a patient's mobility, such as needing to use an ambulatory device. The subscale scoring system ranges from 0-100, with higher scores indicating better knee function.
1 year
Secondary Outcomes (2)
Patient Satisfaction Subscale Score Within the Knee Society Score (KSS) Measure
1 year
Incidents of Major Procedure-related and Device Related Complications (Including Revision Rates)
1 year
Study Arms (6)
ConforMIS iTotal Knee replacement
ACTIVE COMPARATORiTotal patient-specific knee replacement system
DePuy total knee replacement
ACTIVE COMPARATOROff the shelf knee replacement system
Zimmer total knee replacement
ACTIVE COMPARATOROff the shelf knee replacement system
Biomet total knee replacement
ACTIVE COMPARATOROff the shelf knee replacement system
Smith & Nephew total knee replacement
ACTIVE COMPARATOROff the shelf knee replacement system
Stryker total knee replacement
ACTIVE COMPARATOROff the shelf knee replacement system
Interventions
A knee replacement system by DePuy, Zimmer, Biomet, Smith \& Nephew, or Stryker
A knee replacement performed with patient specific implant and surgical jigs.
Eligibility Criteria
You may qualify if:
- Clinical condition included in the approved Indications For Use for the iTotal CR
- Osteoarthritis, as confirmed by the investigator's assessment of disease status at screening visit that warrants a TKR procedure. Disease status is assessed by Clinical and Radiographic assessment
- Willingness to participate in the clinical study, to give informed consent and to attend all follow-up visits
- \> 18 years of age
You may not qualify if:
- Subject will require a simultaneous bilateral procedure
- Other lower extremity surgery within 1 year
- Severe (\> 15º) fixed valgus or varus deformity
- Severe (\> 15º) extension deficit
- Severe instability due to advanced loss of osteochondral structure
- Loss of bone or musculature, osteoporosis, neuromuscular or vascular compromise in the area of the joint to be operated on to an extent that the procedure is unjustified
- Insufficient bone stock on the femoral or tibial surfaces
- Contralateral knee replacement surgery within the past 6 months
- BMI \> 40
- Active malignancy (defined as a history of any invasive malignancy - except non-melanoma skin cancer), unless patient has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least 5 years
- Poorly controlled diabetes (defined as HbA1c \>7 or surgeon discretion)
- Immunocompromised
- Other physical disability affecting the hips, spine, or contralateral knee that limits function
- Disabling chronic pain with narcotic dependence
- Compromised PCL or collateral ligament
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Restor3Dlead
Study Sites (8)
University of California in San Diego
La Jolla, California, 92037, United States
Sharp Healthcare
San Diego, California, 92123, United States
Denver-Vail Orthopedics
Parker, Colorado, 80134, United States
Yale School of Medicine
New Haven, Connecticut, 06520, United States
Tufts University
Boston, Massachusetts, 02111, United States
University of Missouri
Columbia, Missouri, 65212, United States
OrthoNY
Albany, New York, 12205, United States
The Lindner Center for Research and Education
Cincinnati, Ohio, 45219, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Tara Mann - Director of Clinical Affairs
- Organization
- restor3d
Study Officials
- PRINCIPAL INVESTIGATOR
Mary O'Connor, MD
Yale University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Site staff that is performing functional testing on subject is blinded to what implant the patient has.
- Purpose
- BASIC SCIENCE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2015
First Posted
July 10, 2015
Study Start
July 1, 2015
Primary Completion
November 16, 2022
Study Completion
November 16, 2022
Last Updated
November 21, 2025
Results First Posted
October 8, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share